[S(R)]-N-[(1S)-1-[(Diphenylphosphino)methyl]-2,2-dimethylpropyl]-2-methyl-2-propanesulfinamide, 95%, 100mg

4-(3-Bromo-4-fluorophenyl)-3-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one, 98%, 10g

TERT-BUTYL N-(1-CYANOCYCLOBUTYL)CARBAMATE, 95.0%, 1g

Benzyl 5-Bromoamyl Ether>95.0%(GC)5g

Benzyl 2-Naphthyl Ether>98.0%(GC)500g

4-(2-Fluorophenyl)-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 5g

2-Bromopyrazine, 98.00%, 5g

ETHYL 3-(4-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOLE-5-CARBOXYLATE, 97.0%, 1g

2-METHYLBENZOTHIAZOLE-7-CARBOXYLIC ACID, 95.0%, 500mg

Trifluoromethyl 4-fluorobenzenesulfonate, 97%, 250mg

4-fluoro-2-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)aniline, 95.0%, 5g

Pyridine-2,4-diamine, 95.0%, 25g

(R)-methyl 5-((S)-1,1-dimethylethylsulfinamido)-5-(4-morpholinophenyl)-3-oxo-5-(thiophen-3-yl)pentanoate, 97%, 5mg